CYP-006TK

N/A

Report date: 2023/01/12 15:31:56

Base Information

Drug NameCYP-006TK
Drug Alias NameAllogenic mesenchymoangioblast-derived mesenchymal stem cells（Cynata）Cymerus™ MSCs（Cynata）CYP-006-TK
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCynata Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCynata Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A